GEODE CAPITAL MANAGEMENT, LLC
Position in IDXGD — Interpace Biosciences, Inc.
CIK 1214717
BOSTON, MA
Position in IDXGD
as of Dec 31, 2020
· filed Feb 12, 2021
Position Value
$0
+$0 QoQ
Shares Held
32,476
0.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXGD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,517,996,286 across 38 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,382,401 | $4,202,600,564 | |
| 2 | DHR |
Danaher Corp /De/
|
14,280,335 | $2,720,118,210 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,562,886 | $1,349,205,704 | |
| 4 | A |
Agilent Technologies, Inc.
|
7,595,644 | $1,008,929,392 | |
| 5 | WAT |
Waters Corp /De/
|
2,636,146 | $988,660,195 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
4,454,134 | $860,627,771 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
612,153 | $782,031,578 | |
| 8 | NTRA |
Natera, Inc.
|
2,750,013 | $746,491,028 |
All Filings in IDXGD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2020-12-31 | — | 32,476 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | — | 32,476 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | — | 32,476 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 32,476 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||